Trending

Genzyme

Sanofi expects growth as rare disease drugs boost earnings

Sanofi expects growth as rare disease drugs boost earnings

Sanofi’s strategy of betting on new drugs and biotech acquisitions seems to be paying off, as the company

X

Sanofi expects growth as rare disease drugs boost earnings

https://pharmaphorum.com/news/sanofi-expects-growth-as-rare-disease-drugs-boost-earnings/

Sanofi beats expectations, driven by rare diseases and vaccines

Sanofi beats expectations, driven by rare diseases and vaccines

But sales of key insulin fall amid biosimilar competition.

X

Sanofi beats expectations, driven by rare diseases and vaccines

https://pharmaphorum.com/news/sanofi-beats-expectations-driven-rare-diseases-vaccines/

Vericel hopes for US hit with Maci knee treatment

Vericel hopes for US hit with Maci knee treatment

Tissue engineering product previously flopped in EU.

X

Vericel hopes for US hit with Maci knee treatment

https://pharmaphorum.com/transversal-categories/us/vericel-hopes-us-hit-maci-knee-treatment/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com